Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Rapid Delivery of Autologous Bone Marrow Derived Stem Cells in Acute Myocardial Infarction Patients. (AMIRST)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01536106
Recruitment Status : Unknown
Verified September 2013 by TotipotentRX Cell Therapy Pvt. Ltd..
Recruitment status was:  Not yet recruiting
First Posted : February 20, 2012
Last Update Posted : September 4, 2013
TotipotentRX Corporation
Information provided by (Responsible Party):
TotipotentRX Cell Therapy Pvt. Ltd.

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : January 2015
Estimated Study Completion Date : March 2015